target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id LIM domain kinase 1,2054,P53667,Human,compound 31 [PMID: 22902653],8117,,46192505,CCNC(=O)Nc1ncc(s1)c1cc(nc(n1)c1cnccn1)c1c(C)cc(cc1C)OC,"InChI=1S/C23H23N7O2S/c1-5-25-22(31)30-23-27-12-19(33-23)16-10-17(20-13(2)8-15(32-4)9-14(20)3)29-21(28-16)18-11-24-6-7-26-18/h6-12H,5H2,1-4H3,(H2,25,27,30,31)",WUCYRTXFXRZKSV-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.24,,IC50,,58.0,,=,,,,22902653, LIM domain kinase 1,2054,P53667,Human,compound 30 [PMID: 22902653],8118,,58688690,CNC(=O)Nc1ncc(s1)c1nc(nc(c1)c1c(C)cc(cc1C)OC(CC)CC)c1nccnc1,"InChI=1S/C26H29N7O2S/c1-6-17(7-2)35-18-10-15(3)23(16(4)11-18)20-12-19(22-14-30-26(36-22)33-25(34)27-5)31-24(32-20)21-13-28-8-9-29-21/h8-14,17H,6-7H2,1-5H3,(H2,27,30,33,34)",RYXLLTGGHCFCFK-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.64,,IC50,,23.0,,=,,,,22902653, LIM domain kinase 1,2054,P53667,Human,compound 35 [PMID: 22902653],8119,,58688563,COc1cc(Cl)c(c(c1)Cl)c1cc(nc(n1)c1cnccn1)c1cnc(s1)NC(=O)C,"InChI=1S/C20H14Cl2N6O2S/c1-10(29)26-20-25-9-17(31-20)14-7-15(18-12(21)5-11(30-2)6-13(18)22)28-19(27-14)16-8-23-3-4-24-16/h3-9H,1-2H3,(H,25,26,29)",XACSASLXEAYEEO-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.52,,IC50,,30.0,,=,,,,22902653, LIM domain kinase 1,2054,P53667,Human,compound 14 [PMID: 19831390],8151,,44477445,N#CNC(=Nc1cccc(c1)Br)N1CCN(C[C@@H]1C)c1ncnc2c1c(C)c[nH]2,"InChI=1S/C20H21BrN8/c1-13-9-23-18-17(13)19(26-12-25-18)28-6-7-29(14(2)10-28)20(24-11-22)27-16-5-3-4-15(21)8-16/h3-5,8-9,12,14H,6-7,10H2,1-2H3,(H,24,27)(H,23,25,26)/t14-/m0/s1",KSECQYDNQYAZMQ-AWEZNQCLSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,9.3,,IC50,,0.5,,=,,,,19831390, LIM domain kinase 1,2054,P53667,Human,RKI-1447,8152,,60138149,O=C(Nc1scc(n1)c1ccncc1)NCc1cccc(c1)O,"InChI=1S/C16H14N4O2S/c21-13-3-1-2-11(8-13)9-18-15(22)20-16-19-14(10-23-16)12-4-6-17-7-5-12/h1-8,10,21H,9H2,(H2,18,19,20,22)",GDVRVPIXWXOKQO-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.76,,IC50,,1.74,,=,,,,23275831, LIM domain kinase 1,2054,P53667,Human,LIMKi3,9839,,56965901,O=C(C(C)C)Nc1ncc(s1)c1cc(nn1c1c(Cl)cccc1Cl)C(F)F,"InChI=1S/C17H14Cl2F2N4OS/c1-8(2)16(26)23-17-22-7-13(27-17)12-6-11(15(20)21)24-25(12)14-9(18)4-3-5-10(14)19/h3-8,15H,1-2H3,(H,22,23,26)",IVUGBSGLHRJSSP-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.15,,IC50,,7.0,,=,,,,29574791|19001433|20876278|22496574, LIM domain kinase 1,2054,P53667,Human,SR7826,9840,,45381385,OCCN(c1ccccc1)C(=O)Nc1ccc(cc1)c1ncnc2c1c(C)c[nH]2,"InChI=1S/C22H21N5O2/c1-15-13-23-21-19(15)20(24-14-25-21)16-7-9-17(10-8-16)26-22(29)27(11-12-28)18-5-3-2-4-6-18/h2-10,13-14,28H,11-12H2,1H3,(H,26,29)(H,23,24,25)",WQAGVQVBDHOHRD-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.37,,IC50,,43.0,,=,,,,25621531|29574791, LIM domain kinase 1,2054,P53667,Human,voruciclib,9923,,67409219,OC[C@@H]1N(C)CC[C@H]1c1c(O)cc(c2c1oc(cc2=O)c1ccc(cc1Cl)C(F)(F)F)O,"InChI=1S/C22H19ClF3NO5/c1-27-5-4-12(14(27)9-28)19-15(29)7-16(30)20-17(31)8-18(32-21(19)20)11-3-2-10(6-13(11)23)22(24,25)26/h2-3,6-8,12,14,28-30H,4-5,9H2,1H3/t12-,14+/m1/s1",MRPGRAKIAJJGMM-OCCSQVGLSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.66,,IC50,,22.0,,=,,,,26606677, LIM domain kinase 1,2054,P53667,Human,ZAK inhibitor 6p,10402,,138393294,COc1n[nH]c2c1cc(cn2)c1nnn(c1)c1c(F)ccc(c1F)NS(=O)(=O)c1cccc(c1)c1ccccc1,"InChI=1S/C27H19F2N7O3S/c1-39-27-20-13-18(14-30-26(20)32-33-27)23-15-36(35-31-23)25-21(28)10-11-22(24(25)29)34-40(37,38)19-9-5-8-17(12-19)16-6-3-2-4-7-16/h2-15,34H,1H3,(H,30,32,33)",QRDCOOSKIFYKIQ-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pKd,,7.64,,Kd,,23.0,,=,,,,31244114,